AGEN

Antigentics Inc. is rippin in pre market trading this morning. The company reportedly seeing positive survival data in it's phase 3 Melastatic Melanoma Trial. The company has scheduled a conference call for 9 am. today. Keep this stock on that trading radar.

Budd Foxx